Topical Antibiotic Prophylaxis for Eyelids

PHASE4CompletedINTERVENTIONAL
Enrollment

401

Participants

Timeline

Start Date

October 2, 2017

Primary Completion Date

November 14, 2019

Study Completion Date

November 14, 2019

Conditions
Antibiotic Side EffectEyelid; WoundEyelid DiseasesSurgical Wound InfectionSurgical Wound, RecentSurgical IncisionSkin Cancer FaceAntibiotic AllergySurgical Site Infection
Interventions
DRUG

Topical Antibiotic Product

Topical antibiotic ointment will be erythromycin or bacitracin. If the patient cannot obtain either (e.g. lack of availability at the pharmacy), bacitracin polymyxin will be prescribed. Allergy to all 3 study drugs means that a patient will be excluded from the study.

DRUG

Topical Non-Antibiotic Ointment

Mineral oil/petrolatum-based artificial tear ointment.

Trial Locations (1)

94143

University of California, San Francisco, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER

NCT03199911 - Topical Antibiotic Prophylaxis for Eyelids | Biotech Hunter | Biotech Hunter